SecBot SecBot
SECBOTREPLAY Home › Report › ARQT

ARQT · Two officers of Arcutis Biotherapeutics filed Form 144 notices on…

Arcutis Biotherapeutics, Inc. · 144 filed Nov 2, 2026 at 17:27 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 2, 2026 at 17:27 ET

Two officers of Arcutis Biotherapeutics filed Form 144 notices on November 2, 2026, signaling intent to sell shares. Officer Masaru Matsuda plans to sell 1,219 shares (~$38,841) and Officer Patrick Burnett plans to sell 943 shares (~$30,047), both acquired through restricted stock vesting on November 1, 2026. The proposed sales are small relative to the company's $4.0B market cap and the officers' recent prior sales, making this a routine insider transaction with limited market impact.

  • Masaru Matsuda (Officer) filed Form 144 to sell 1,219 shares of common stock, estimated value $38,841.48.
  • Patrick Burnett (Officer) filed Form 144 to sell 943 shares of common stock, estimated value $30,047.19.
  • Both proposed sales are for shares acquired through restricted stock vesting on November 1, 2026.
  • Proposed sale date for both is November 2, 2026, on Nasdaq.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access